CellWell record HH-0434
Melatonin and cancer-patient sleep, review of 6 studies
Jafari-Koulaee A; Bagheri-Nesami M
review
In plain language
A review of melatonin (roughly 3-20 mg, 10 days to 4 months) in cancer patients found benefit in 4 of 6 studies reviewed.
- Design
- Systematic review
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-0434
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.